WAYRILZ

Medicinal product

(Invented) name

WAYRILZ

Active substance (s)

Rilzabrutinibas

Strength

400 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

Nesuteiktas, Netaikoma ar nesuteiktas

Marketing authorisation holder

Sanofi B.V., Nyderlandai

Date of authorisation

2025-12-22

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Rilzabrutinibas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119510	105616	1105616	lizdinė plokštelė	N28		Receptinis	EU/1/25/1974/001	Netiekiama	-	-	No	-	-
119511	105617	1105617	lizdinė plokštelė	N56 (2×28)		Receptinis	EU/1/25/1974/002	Netiekiama	-	-	No	-	-
119512	105618	1105618	lizdinė plokštelė	N196 (7×28)		Receptinis	EU/1/25/1974/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-12-22	Registruotas